PBS with 0.1 mg/ml rAlbumin and 0.05% sodium azide
Form:
Liquid
Target:
HLA-DPB1, HLA-DQA1
Application Notes:
Application Notes: WB: 1-2 µg/mLImmunofluorescence: 0.5-1 µg/mLImmunohistochemistry (FFPE): 1-2 µg/mL for 30 min at RTOptimal dilution of the HLA-DP/DQ/DR antibody should be determined by the researcher
IHC testing of FFPE human tonsil tissue with HLA-DP/DQ/DR antibody (clone CR3/43). Required HIER: boil tissue sections in 10mM citrate buffer, pH 6, for 10-20 min.
IHC testing of FFPE human tonsil tissue with HLA-DP/DQ/DR antibody (clone CR3/43). Required HIER: boil tissue sections in 10mM citrate buffer, pH 6, for 10-20 min.
Western blot testing of human Raji cell lysate with HLA-DP/DQ/DR antibody (clone CR3/43). Expected molecular weight ~36 kDa (alpha chain) and ~27 kDa (beta chain).
SDS-PAGE Analysis of Purified, BSA-Free HLA-DP/DQ/DR Antibody (clone CR3/43). Confirmation of Integrity and Purity of the Antibody.
IF/ICC staining of human Raji cells with HLA-DP/DQ/DR antibody (green) and Reddot nuclear stain (red).
Flow cytometry testing of human Raji cells with HLA-DP/DQ/DR antibody at 1 ug/10 6 cells (blocked with goat sera), Red = isotype control, Blue = HLA-DP/DQ/DR antibody.
* VAT and and shipping costs not included. Errors and price changes excepted
